Erysipelas presenting in a neonate — a patient under one month of age — is a distinct clinical scenario. The patient's age is the key factor shaping the treatment pathway and antibiotic selection.
This protocol applies specifically to patients aged under 1 month with erysipelas. Neonatal age is the defining condition here, and it directly determines how antibiotic treatment is approached.
In this age group, antibiotic selection is not made on a standard formulary basis — choice is based on specialist advice. The full structured protocol sets out what that specialist-directed approach involves.